IOVANCE BIOTHERAPEUTICS, INC.

IOVA

Form 4 • Statement of Changes in Beneficial Ownership

SEC Accession Number: 0001104659-26-023537
Filing date: Mar 4, 2026
Earliest execution date: Mar 2, 2026

Summary

Type

Sell

Net shares

-2,798

% of shares

-1.26%

Amount (USD)

$10,604

Insider confidence score

46.3 out of 100

Positive

  • Tax withholding obligation
  • Small sell amount (<$50K)

Negative

  • Large tax withholding sell (≥1% of shares)

Stock transactions

Transaction 1

Security

Common Stock

Action

Exercise

Date

2026-03-02

Code

M

Net shares

+5,470.0

Acquired/Disposed

Acquired

Shares Owned Before

215,859.0

Shares Owned After

221,329.0

Transaction 2

Security

Common Stock

Action

Tax_withhold

Date

2026-03-02

Code

F

Net shares

-2,798.0

Price per Share

$3.79

Amount (USD)

$10,604.42

Acquired/Disposed

Disposed

Shares Owned Before

221,329.0

Shares Owned After

218,531.0

Derivative Transactions

Transaction 1

Security

Restricted Stock Units

Action

Exercise

Date

2026-03-02

Code

M

Net shares

-5,470.0

Acquired/Disposed

Disposed

Shares Owned Before

27,348.0

Shares Owned After

21,878.0

Filing's footnotes

1. Represents such shares underlying the restricted stock units (&quot;RSUs&quot;) which vested on the transaction date.

2. Represents shares withheld by the Issuer to satisfy the mandatory tax withholding requirements upon vesting of the RSUs. This is not an open market sale of securities.

3. Represents the common stock remaining after deducting the common stock withheld for taxes.

4. Each RSU represents a contingent right to receive one share of the Issuer's common stock.

5. The remaining RSUs will vest in equal quarterly installments.

6. Such aggregate number reflects the remainder of such RSUs granted on March 1, 2024, but does not include any other RSUs held by such Reporting Person.

This page is for informational purposes only. While we strive for accuracy, the summary may contain inaccuracies or omissions. Please refer to the official SEC filing for authoritative information. Open the SEC filing.